Ocugen Inc (OCGN) concluded trading on Wednesday at a closing price of $0.73, with 7.25 million shares of worth about $5.29 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -62.62% during that period and on January 15, 2025 the price saw a loss of about -0.60%. Currently the company’s common shares owned by public are about 290.26M shares, out of which, 286.08M shares are available for trading.
Stock saw a price change of -16.80% in past 5 days and over the past one month there was a price change of -14.49%. Year-to-date (YTD), OCGN shares are showing a performance of -9.45% which increased to 21.77% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.49 but also hit the highest price of $2.11 during that period. The average intraday trading volume for Ocugen Inc shares is 4.57 million. The stock is currently trading -9.50% below its 20-day simple moving average (SMA20), while that difference is down -17.41% for SMA50 and it goes to -42.14% lower than SMA200.
Ocugen Inc (NASDAQ: OCGN) currently have 290.26M outstanding shares and institutions hold larger chunk of about 27.53% of that.
The stock has a current market capitalization of $212.35M and its 3Y-monthly beta is at 3.87. It has posted earnings per share of -$0.18 in the same period. It has Quick Ratio of 2.58 while making debt-to-equity ratio of 0.17. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OCGN, volatility over the week remained 7.91% while standing at 9.13% over the month.
Stock’s fiscal year EPS is expected to rise by 22.12% while it is estimated to decrease by -25.93% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on October 15, 2024 offering a Buy rating for the stock and assigned a target price of $4 to it. Coverage by Chardan Capital Markets stated Ocugen Inc (OCGN) stock as a Buy in their note to investors on March 01, 2023, suggesting a price target of $3.50 for the stock. On August 23, 2022, Mizuho Initiated their recommendations, while on June 15, 2022, ROTH Capital Resumed their ratings for the stock with a price target of $8. Stock get an Overweight rating from Cantor Fitzgerald on June 02, 2022.
